Main menu

Unlocking the biopharma development pipeline with Oxford Nanopore


Introductory guide: biopharma — 2 pages

Overview

The current drug development process can be long, complex, and resource-intensive. One major bottleneck is the use of a compendium of conventional assays and analytical tools, which have inherent limitations that restrict efficiency, accuracy, scalability, and fast decision-making.

In this introductory guide, discover how a new generation of molecular sensing technology from Oxford Nanopore is transforming the biopharma development pipeline. Oxford Nanopore sequencing is a single-platform solution that is streamlining the process from discovery to clinical development:

  • Novel biomarker discovery and target identification
  • Candidate identification
  • Construct characterisation
  • Expression optimisation
  • Viral vector characterisation
  • Cell line development
  • Quality control release testing
  • Clinical development and post-market surveillance

Download

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
English flag